NYSE:COR
NYSE:CORHealthcare

Cencora (COR) Valuation Check As Rapiblyk Distribution Highlights Role In Critical Care Therapy Launches

AOP Health US is expanding access to its critical care drug Rapiblyk across U.S. hospitals through distributors including Cencora (COR), highlighting how Cencora’s specialty distribution footprint supports new therapy launches. See our latest analysis for Cencora. The Rapiblyk rollout arrives alongside a solid run in Cencora’s shares, with a 1-day share price return of 1.55% and 7-day share price return of 5.84% helping extend a 90-day share price return of 9.44%. Over a longer horizon, total...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Is It Too Late To Consider Lam Research (LRCX) After A 177% One Year Surge?

If you are wondering whether Lam Research is still reasonably priced after its strong run, this article walks through what the numbers actually say about the stock's value. The share price recently closed at US$217.47, with returns of 8.2% over 7 days, 33.2% over 30 days, 17.5% year to date, 177.0% over 1 year and 394.4% over 3 years. These figures can change how investors think about both upside potential and risk. Recent coverage has focused on Lam Research as a key player in the...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

A Closer Look At AeroVironment (AVAV) Valuation After Sharp Share Price Momentum

Why AeroVironment is on investors’ radar AeroVironment (AVAV) shares have moved sharply over the past month, with the stock returning about 61%, putting fresh attention on how its current valuation lines up with recent financial results. See our latest analysis for AeroVironment. At a share price of $378.57, AeroVironment’s recent 30 day share price return of 61.33% and 1 year total shareholder return of 128.90% point to strong momentum building around the stock, in addition to a 360.60%...
HLSE:KCR
HLSE:KCRMachinery

How Investors Are Reacting To Konecranes (HLSE:KCR) US Navy Crane And Hybrid Port Orders

Konecranes has announced a US$49.7 million order for a sixth heavy-lift portal jib crane from the US Navy, alongside a separate order from Port Newark Container Terminal for 20 hybrid straddle carriers to be delivered in Fourth Quarter 2026. Together, these contracts highlight Konecranes’ ability to win repeat defense business while expanding its eco-efficient port equipment footprint at a major US terminal. We’ll now examine how this combination of repeat US Navy work and hybrid straddle...